
Black Diamond Therapeutics, Inc.
USD1.87
+0.06 (+3.31%)
CEO
Mark A. Velleca
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.81
Prev. Close
$1.81
Day Low
$1.79
Day High
$1.88
52W Low
$1.60
52W High
$4.94
Market Cap
$0.11B
Volume
0.48M
Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations